Trial intelligence / Profile preview

Influence of MDR1 Genotype on Indinavir and Saquinavir Pharmacokinetics in Healthy Volunteers

NCT00050180Phase 4Completed

Sponsor
National Institutes of Health
Start
Nov 2002
Primary completion
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of indinavir, saquinavir in human immunodeficiency virus infection (HIV), sponsored by National Institutes of Health. Started Nov 2002; status: completed.

02

Drugs

indinavirsaquinavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00050180.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00050180.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call